Paulo Yen
Foot Surgery · Clarksville, TNNPI 1982621603
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for foot surgery clinicians in TN, where the typical reported total is $1,166.
Across 11 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$33
- Organogenesis Inc.$29
- Amgen$29
- Averitas Pharma Inc.$28
- ANI Pharmaceuticals, Inc.$24
- Paratek Pharmaceuticals, Inc.$24
- plus $71 from 4 others
What the payments were for
- Food & beverage$238100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 2 | $33 |
| Organogenesis Inc. | 1 | $29 |
| Amgen | 1 | $29 |
| Averitas Pharma Inc. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $23 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Convatec Inc. | 1 | $15 |
| Advanced Oxygen Therapy Inc. | 1 | $12 |
How this compares
$238 in reported general payments places this provider in the 25th percentile of 23 foot surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 69 | $1,896 |
| Ciclopirox | 23 | $760 |
| Econazole Nitrate | 11 | $261 |
| SsdSilver Sulfadiazine | 27 | $214 |
| Cephalexin | 15 | $184 |
| Terbinafine Hcl | 13 | $111 |
| Methylprednisolone | 15 | $107 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $58 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Clarksville
- Christopher JuelsCookeville$208K
- Joseph CreazzoMorristown$12K
- David VelardeKnoxville$11K
- David FranklinAlcoa$8K
- Carol AkermanKnoxville$6K
- Mark WrightMurfreesboro$5K
- James EngblomOak Ridge$2K
- David MoinesterMemphis$2K
- Brian ShwerMemphis$2K
- Brian ChristiansenOak Ridge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.